Comparison of mHealth and Face-to-Face Interventions for Smoking Cessation Among People Living With HIV: Meta-Analysis

Olalekan A Uthman, Chidozie U Nduka, Mustapha Abba, Rocio Enriquez, Helena Nordenstedt, Fred Nalugoda, Andre P Kengne, Anna M Ekström, Olalekan A Uthman, Chidozie U Nduka, Mustapha Abba, Rocio Enriquez, Helena Nordenstedt, Fred Nalugoda, Andre P Kengne, Anna M Ekström

Abstract

Background: The prevalence of smoking among people living with HIV (PLHIV) is higher than that reported in the general population, and it is a significant risk factor for noncommunicable diseases in this group. Mobile phone interventions to promote healthier behaviors (mobile health, mHealth) have the potential to reach a large number of people at a low cost. It has been hypothesized that mHealth interventions may not be as effective as face-to-face strategies in achieving smoking cessation, but there is no systematic evidence to support this, especially among PLHIV.

Objective: This study aimed to compare two modes of intervention delivery (mHealth vs face-to-face) for smoking cessation among PLHIV.

Methods: Literature on randomized controlled trials (RCTs) investigating effects of mHealth or face-to-face intervention strategies on short-term (4 weeks to <6 months) and long-term (≥6 months) smoking abstinence among PLHIV was sought. We systematically reviewed relevant RCTs and conducted pairwise meta-analyses to estimate relative treatment effects of mHealth and face-to-face interventions using standard care as comparison. Given the absence of head-to-head trials comparing mHealth with face-to-face interventions, we performed adjusted indirect comparison meta-analyses to compare these interventions.

Results: A total of 10 studies involving 1772 PLHIV met the inclusion criteria. The average age of the study population was 45 years, and women comprised about 37%. In the short term, mHealth-delivered interventions were significantly more efficacious in increasing smoking cessation than no intervention control (risk ratio, RR, 2.81, 95% CI 1.44-5.49; n=726) and face-to-face interventions (RR 2.31, 95% CI 1.13-4.72; n=726). In the short term, face-to-face interventions were no more effective than no intervention in increasing smoking cessation (RR 1.22, 95% CI 0.94-1.58; n=1144). In terms of achieving long-term results among PLHIV, there was no significant difference in the rates of smoking cessation between those who received mHealth-delivered interventions, face-to-face interventions, or no intervention. Trial sequential analysis showed that only 15.16% (726/1304) and 5.56% (632/11,364) of the required information sizes were accrued to accept or reject a 25% relative risk reduction for short- and long-term smoking cessation treatment effects. In addition, sequential monitoring boundaries were not crossed, indicating that the cumulative evidence may be unreliable and inconclusive.

Conclusions: Compared with face-to-face interventions, mHealth-delivered interventions can better increase smoking cessation rate in the short term. The evidence that mHealth increases smoking cessation rate in the short term is encouraging but not sufficient to allow a definitive conclusion presently. Future research should focus on strategies for sustaining smoking cessation treatment effects among PLHIV in the long term.

Keywords: HIV; mHealth; smoking cessation.

Conflict of interest statement

Conflicts of Interest: OAU is supported by the National Institute of Health Research using Official Development Assistance funding and Wellcome Trust strategic award. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health, or Wellcome Trust.

©Olalekan A Uthman, Chidozie U Nduka, Mustapha Abba, Rocio Enriquez, Helena Nordenstedt, Fred Nalugoda, Andre P Kengne, Anna M Ekström. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 07.01.2019.

Figures

Figure 1
Figure 1
Adjusted indirect comparison network meta-analysis framework. A: mhealth delivered; B: face to face; C: standard of care.
Figure 2
Figure 2
Trial sequential analysis.
Figure 3
Figure 3
Study selection flow diagram. SMS: short message service.
Figure 4
Figure 4
Risk of bias in included studies.
Figure 5
Figure 5
Pairwise comparisons of all interventions, short-term effect. RR: risk ratio; SMS: short message service; SoC: standard of care, no intervention control.
Figure 6
Figure 6
Trial sequential analysis for mHealth for smoking cessation in people living with HIV, short-term effect. mHealth: mobile health.
Figure 7
Figure 7
Pairwise comparisons of all interventions, long-term effect. RR: risk ratio; SMS: short message service; SoC: standard of care, no intervention control.
Figure 8
Figure 8
Trial sequential analysis for mHealth for smoking cessation in people living with HIV, long-term effect. mHealth: mobile health.

References

    1. Dalal S, Beunza JJ, Volmink J, Adebamowo C, Bajunirwe F, Njelekela M, Mozaffarian D, Fawzi W, Willett W, Adami H, Holmes MD. Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol. 2011 Aug;40(4):885–901. doi: 10.1093/ije/dyr050.
    1. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010 Feb;35(2):72–115. doi: 10.1016/j.cpcardiol.2009.10.002.
    1. Petersen M, Yiannoutsos CT, Justice A, Egger M. Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations. J Acquir Immune Defic Syndr. 2014 Sep;67 Suppl 1:S8–16. doi: 10.1097/QAI.0000000000000253.
    1. WHO. Geneva, Switzerland: World Health Organization; 2008. [2018-11-15]. WHO REPORT on the global TOBACCO epidemic, 2008
    1. WHO. Geneva, Switzerland: World Health Organization; 2017. [2018-11-15]. WHO global report on trends in prevalence of tobacco smoking 2015
    1. Lawrence D, Mitrou F, Zubrick SR. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health. 2009 Aug;9:285. doi: 10.1186/1471-2458-9-285.
    1. Baggett TP, Rigotti NA. Cigarette smoking and advice to quit in a national sample of homeless adults. Am J Prev Med. 2010 Aug;39(2):164–72. doi: 10.1016/j.amepre.2010.03.024.
    1. Kelly PJ, Baker AL, Deane FP, Kay-Lambkin FJ, Bonevski B, Tregarthen J. Prevalence of smoking and other health risk factors in people attending residential substance abuse treatment. Drug Alcohol Rev. 2012 Jul;31(5):638–44. doi: 10.1111/j.1465-3362.2012.00465.x.
    1. Cropsey K, Eldridge G, Weaver M, Villalobos G, Stitzer M, Best A. Smoking cessation intervention for female prisoners: addressing an urgent public health need. Am J Public Health. 2008 Oct;98(10):1894–901. doi: 10.2105/AJPH.2007.128207.
    1. Shuter J, Bernstein S. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res. 2008 Apr;10(4):731–6. doi: 10.1080/14622200801908190.
    1. Twyman L, Bonevski B, Paul C, Bryant J. Perceived barriers to smoking cessation in selected vulnerable groups: a systematic review of the qualitative and quantitative literature. BMJ Open. 2014 Dec;4(12):e006414. doi: 10.1136/bmjopen-2014-006414.
    1. Pool ERM, Dogar O, Lindsay RP, Weatherburn P, Siddiqi K. Interventions for tobacco use cessation in people living with HIV and AIDS. Cochrane Database Syst Rev. 2016 Jun;(6):CD011120. doi: 10.1002/14651858.CD011120.pub2.
    1. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005 Mar;100(3):299–303. doi: 10.1111/j.1360-0443.2004.00995.x.
    1. Higgins JPT, Altman DG, Gøtzsche Peter C, Jüni Peter, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC, Cochrane Bias Methods Group. Cochrane Statistical Methods Group The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011 Oct;343:d5928.
    1. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997 Jun;50(6):683–91.
    1. Song F, Altman DG, Glenny A, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003 Mar 01;326(7387):472. doi: 10.1136/bmj.326.7387.472.
    1. Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D'Amico R, Bradburn M, Eastwood AJ, International Stroke Trial Collaborative Group Indirect comparisons of competing interventions. Health Technol Assess. 2005 Jul;9(26):1–134, iii.
    1. Gartlehner G, Moore CG. Direct versus indirect comparisons: a summary of the evidence. Int J Technol Assess Health Care. 2008;24(2):170–7. doi: 10.1017/S0266462308080240.
    1. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008 Aug;61(8):763–9. doi: 10.1016/j.jclinepi.2007.10.007.
    1. Higgins JPT, Whitehead A, Simmonds M. Sequential methods for random-effects meta-analysis. Stat Med. 2011 Apr 30;30(9):903–21. doi: 10.1002/sim.4088. doi: 10.1002/sim.4088.
    1. Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol. 2009 Dec 30;9:86. doi: 10.1186/1471-2288-9-86.
    1. Pogue JM, Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials. 1997 Dec;18(6):580–93; discussion 661.
    1. Humfleet GL, Hall SM, Delucchi KL, Dilley JW. A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings. Nicotine Tob Res. 2013 Aug;15(8):1436–45. doi: 10.1093/ntr/ntt005.
    1. Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav. 2009 Jun;13(3):545–54. doi: 10.1007/s10461-007-9334-4.
    1. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Shadel WG, Stein M, Tashima K, Flanigan T, Morrow K, Neighbors C, Niaura R. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction. 2009 Nov;104(11):1891–900. doi: 10.1111/j.1360-0443.2009.02623.x.
    1. Manuel JK, Lum PJ, Hengl NS, Sorensen JL. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS Care. 2013;25(7):820–7. doi: 10.1080/09540121.2012.733331.
    1. Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr. 2012 Oct 01;61(2):208–15. doi: 10.1097/QAI.0b013e3182645679.
    1. Shelley D, Tseng T, Gonzalez M, Krebs P, Wong S, Furberg R, Sherman S, Schoenthaler A, Urbina A, Cleland CM. Correlates of Adherence to Varenicline Among HIV+ Smokers. Nicotine Tob Res. 2015 Aug;17(8):968–74. doi: 10.1093/ntr/ntv068.
    1. Shuter J, Morales DA, Considine-Dunn SE, An LC, Stanton CA. Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2014 Sep 01;67(1):59–66. doi: 10.1097/QAI.0000000000000226.
    1. Tucker JS, Shadel WG, Galvan FH, Naranjo D, Lopez C, Setodji C. Pilot evaluation of a brief intervention to improve nicotine patch adherence among smokers living with HIV/AIDS. Psychol Addict Behav. 2017 Dec;31(2):148–153. doi: 10.1037/adb0000221.
    1. Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS. 2006 Jan 09;20(2):253–60. doi: 10.1097/01.aids.0000198094.23691.58.
    1. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012 Jan;14(1):106–10. doi: 10.1093/ntr/ntr121.
    1. Spohr SA, Nandy R, Gandhiraj D, Vemulapalli A, Anne S, Walters ST. Efficacy of SMS Text Message Interventions for Smoking Cessation: A Meta-Analysis. J Subst Abuse Treat. 2015 Sep;56:1–10. doi: 10.1016/j.jsat.2015.01.011.
    1. Miranda JJ, Kinra S, Casas JP, Davey SG, Ebrahim S. Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health. 2008 Oct;13(10):1225–34. doi: 10.1111/j.1365-3156.2008.02116.x. doi: 10.1111/j.1365-3156.2008.02116.x.
    1. Wewers ME, Neidig JL, Kihm KE. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J Assoc Nurses AIDS Care. 2000;11(6):37–44. doi: 10.1016/S1055-3290(06)60353-1.

Source: PubMed

3
Abonner